VOLITIONRX LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.72 USD | -0.98% |
|
-1.04% | +0.42% |
| May. 14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
| May. 13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar VolitionRx Limited
8660b2c5f4cfba86f509cba7d10.-j5xZMNzi_U65a0AK27z6XMO8fEDVsaqbeDb9OBE4vU.rwgVPqQ1-aJVgZt1Gla0jwlgkJ95DPXhGJbpnKUrrrvCekZTpiPFpGOU7A~a5ef47b8f9258a0b67c72e93ba84ee90
Upcoming events on VolitionRx Limited
Past events on VolitionRx Limited
| 2024-05-20 | Benchmark Healthcare House Virtual Conference |
| 2024-05-14 | EF Hutton Investor Conference |
| 2024-05-14 08:30 am | Q1 2024 Earnings Call |
| 2024-05-13 04:10 pm | Q1 2024 Earnings Release |
| 2024-04-09 08:30 am | LD Micro Invitational Conference |
| 2024-03-26 08:30 am | Q4 2023 Earnings Call |
| 2024-03-25 04:10 pm | Q4 2023 Earnings Release |
| 2024-02-13 10:30 am | Business Update Call |
| 2023-12-06 04:00 pm | Sidoti December Small-Cap Conference |
| 2023-11-15 08:30 am | Q3 2023 Earnings Call |
| 2023-11-14 04:10 pm | Q3 2023 Earnings Release |
| 2023-10-26 10:30 am | European Society for Medical Oncology Congress |
| 2023-10-21 | European Society for Medical Oncology Congress - Presentation Number:133MO |
| 2023-10-21 | European Society for Medical Oncology Congress - Presentation Number:524P |
| 2023-10-20 | European Society for Medical Oncology Congress - Presentation Number:205P |
| 2023-10-04 06:00 pm | LD Micro Main Conference |
| 2023-08-15 08:30 am | Q2 2023 Earnings Call |
| 2023-08-14 04:10 pm | Q2 2023 Earnings Release |
| 2023-06-23 08:00 am | Annual General Meeting |
| 2023-06-20 11:30 am | Maxim Group Virtual Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,02 -18.57% | 0,01 0,01 30.52% | 0,09 0,10 -11.92% | 0,31 0,37 -18.02% | 0,78 1,05 -26.27% | 2,97 |
|
EBITDA Million USD | Released Forecast Spread | -15,8 -18,2 13.14% | -20,5 -17,1 -20.07% | 0,00 0,00 - | -27,7 -28,4 2.19% | -32,5 -31,6 -2.99% | -31,7 |
|
EBIT Million USD | Released Forecast Spread | -16,0 -17,2 6.73% | -21,2 -20,3 -4.54% | -28,3 -27,0 -4.95% | -31,8 -32,1 0.88% | -36,0 -35,7 -0.81% | -33,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,1 -17,5 7.95% | -20,4 -20,1 -1.38% | -27,0 -25,8 -4.59% | -30,6 -31,7 3.48% | -35,7 -35,5 -0.5% | -33,3 |
|
Net income Million USD | Released Forecast Spread | -16,1 -17,5 7.75% | -20,4 -20,0 -1.85% | -26,8 -26,3 -2.06% | -30,3 -31,6 4.14% | -35,3 -35,4 0.32% | -33,9 |
|
EPS USD | Released Forecast Spread | -0,41 -0,45 7.87% | -0,45 -0,45 -0.9% | -0,51 -0,50 -3.03% | -0,55 -0,57 3.85% | -0,50 -0,47 -5.63% | -0,42 |
| Announcement Date | 20/02/20 | 22/03/21 | 30/03/22 | 15/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,11 10,0 -98.86% | 0,04 0,11 -64.14% | 0,03 0,09 -65.33% | 0,12 0,18 -33.41% | 0,15 0,42 -64.14% | 0,22 0,27 -20.25% | 0,17 0,35 -52.33% | 0,24 0,51 -51.75% | 0,17 0,39 -55.96% | 0,53 | 0,86 | 1,46 | 1,30 | 1,80 |
|
EBITDA Million USD | Released Forecast Spread | -8,08 -7,45 -8.45% | -7,82 -9,20 15.01% | -7,98 -7,10 -12.37% | -7,71 -8,30 7.11% | -8,20 | -8,20 | -7,70 | |||||||
|
EBIT Million USD | Released Forecast Spread | -7,68 0,96 -898.34% | -8,10 -7,83 -3.41% | -7,99 -8,22 2.73% | -8,01 -8,21 2.4% | -9,05 -8,39 -7.82% | -9,55 -9,43 -1.24% | -8,65 -9,93 12.85% | -8,74 -8,50 -2.83% | -8,38 -8,88 5.61% | -8,73 | -8,62 | -8,32 | -6,40 | -5,60 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,72 0,45 -1815.11% | -7,73 -7,85 1.5% | -7,81 -8,14 4.02% | -7,34 -8,18 10.33% | -8,87 -8,44 -5.15% | -9,55 -9,34 -2.22% | -8,45 -9,95 15.05% | -8,80 -8,67 -1.53% | -8,47 -8,93 5.16% | -8,80 | -8,77 | -8,57 | -6,40 | -5,60 |
|
Net income Million USD | Released Forecast Spread | -7,63 1,07 -816.57% | -7,65 -7,87 2.74% | -7,74 -8,24 6.02% | -7,24 -8,20 11.72% | -8,78 -8,40 -4.47% | -9,47 -9,31 -1.7% | -8,37 -9,91 15.57% | -8,70 -8,63 -0.75% | -8,37 -8,98 6.84% | -8,86 | -8,82 | -8,52 | -6,40 | -5,60 |
|
EPS USD | Released Forecast Spread | -0,14 0,02 -900% | -0,14 -0,15 3.45% | -0,14 -0,15 5.41% | -0,13 -0,15 10.96% | -0,15 -0,14 -9.09% | -0,14 -0,15 4.11% | -0,11 -0,13 15.38% | -0,11 -0,11 -3.12% | -0,10 -0,11 9.09% | -0,11 | -0,10 | -0,10 | -0,07 | -0,06 |
| Announcement Date | 11/05/22 | 10/08/22 | 14/11/22 | 15/03/23 | 10/05/23 | 14/08/23 | 14/11/23 | 25/03/24 | 13/05/24 | - | - | - | - | - |
More events
Past sector events for VolitionRx Limited
| 2024-05-09 | SEEGENE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | VERACYTE, INC.: Q1 2024 Earnings Release |
| 2024-04-26 | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-12 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | CAREDX, INC: Q4 2023 Earnings Release |
| 2024-02-28 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VNRX Stock
- Calendar VolitionRx Limited
